Top Markets
Coin of the day
Lattice Biologics Ltd. Lattice Biologics Ltd.

Lattice Biologics Ltd.

LBLTF
Rangering i aksjer #41555
Lattice Biologics Ltd. is a biotechnology firm focused on developing,... Lattice Biologics Ltd. is a biotechnology firm focused on developing, manufacturing, and commercializing biological products designed for bone regeneration. These solutions are utilized globally across dental, spinal, and general orthopedic indications. The company's innovative offerings include novel amniotic fluid-based therapies such as AmnioBoost and AmnioBlast. In addition, their product line features a broad range of allografts, encompassing traditional, spinal, particulate, soft tissue, dental, membrane and barrier, and demineralized bone matrix varieties. These versatile products serve numerous critical medical applications, from enhancing spinal fusion and aiding breast reconstruction post-mastectomy to promoting bone regeneration in foot and ankle surgeries and fostering skull healing after neurosurgery. They also play a role in improving wound repair for burn victims, facilitating hernia repair, addressing subchondral bone defects in knee and other joint surgeries, and supporting various sports medicine procedures, including anterior and posterior cruciate ligament repairs. The company's headquarters are located in Belgrade, Montana.
Aksjekurs
$0.0001
Sist synkronisert: 2026-08-11
Markedsverdi
$16.55K
Endring (1 dag)
0.00%
Endring (1 år)
0.00%
Land
US
Handel Lattice Biologics Ltd. (LBLTF)

Kategori

Inntekter for Lattice Biologics Ltd. (LBLTF)
Inntekter i 2026 TTM: 0
Ifølge Lattice Biologics Ltd. sine nyeste økonomiske rapporter er selskapets nåværende resultat 0. I 2026 hadde selskapet et resultat på 0, lik resultatet i 2026, som var 0. Resultatet som vises på denne siden er resultat før renter og skatt, eller EBIT.
Inntektshistorikk for Lattice Biologics Ltd. fra 2026 til 2026
Inntekter ved slutten av hvert år
År Inntekter Endre
Ikke nok data for de angitte datoene.
Inntekter for lignende selskaper eller konkurrenter
Selskap Inntekter Forskjell i inntekter Land
$7.51B -
US
$5.15B -
US
$5.56B -
IE
$3.86B -
US
$1.42B -
US